Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Randomized, Controlled Phase 2 Proof-of-Concept Study of the Use of Favipiravir Compared to Standard of Care in Hospitalized Subjects With COVID-19

NCT04358549 is registered in ClinicalTrials.gov with Fujifilm Pharmaceuticals U.S.A., Inc. as lead sponsor.

NCT NCT04358549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04358549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Randomized, Controlled Phase 2 Proof-of-Concept Study of the Use of Favipiravir Compared to Standard of Care in Hospitalized Subjects With COVID-19
Lead sponsor
Fujifilm Pharmaceuticals U.S.A., Inc.
Phase
Phase 2
Overall status
Completed
Start date
April 17, 2020
Completion date
October 30, 2020
Enrollment
50 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19